These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 2680337

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prevention of amphotericin B-induced renal impairment. A review on the use of sodium supplementation.
    Branch RA.
    Arch Intern Med; 1988 Nov; 148(11):2389-94. PubMed ID: 3056312
    [Abstract] [Full Text] [Related]

  • 4. Intralipid in prophylaxis of amphotericin B nephrotoxicity.
    Vita E, Schroeder DJ.
    Ann Pharmacother; 1994 Oct; 28(10):1182-3. PubMed ID: 7841575
    [No Abstract] [Full Text] [Related]

  • 5. Mortality rates in comparative trials of formulations of amphotericin B.
    Frothingham R.
    Clin Infect Dis; 2001 Aug 15; 33(4):582-3. PubMed ID: 11462201
    [No Abstract] [Full Text] [Related]

  • 6. Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex.
    Craddock C, Anson J, Chu P, Dodgson A, Duncan N, Gomez C, Mehta J, Sadullah S, Subudhi C, Yin JL.
    Expert Opin Drug Saf; 2010 Jan 15; 9(1):139-47. PubMed ID: 19947901
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lack of nephrotoxicity with the administration of amphotericin B in a lipid emulsion.
    Smith TM, Strozyk WR.
    Ann Pharmacother; 1994 Nov 15; 28(11):1307-8. PubMed ID: 7849357
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Letter: Amphotericin pharmacophobia and renal toxicity.
    Forgan-Smith R, Darrell JH.
    Br Med J; 1974 Feb 09; 1(5901):244. PubMed ID: 4818170
    [No Abstract] [Full Text] [Related]

  • 13. [Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial].
    Rieger CT, Dittmer M, Ostermann H.
    Dtsch Med Wochenschr; 2007 Oct 09; 132(40):2062-6. PubMed ID: 17899499
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of systemic fungal infections with liposomal amphotericin B.
    Lopez-Berestein G, Bodey GP, Fainstein V, Keating M, Frankel LS, Zeluff B, Gentry L, Mehta K.
    Arch Intern Med; 1989 Nov 09; 149(11):2533-6. PubMed ID: 2818111
    [Abstract] [Full Text] [Related]

  • 16. [Amphotericin B: the end of an era].
    Oude Lashof AM, Kullberg BJ.
    Ned Tijdschr Geneeskd; 2004 Aug 21; 148(34):1665-8. PubMed ID: 15453116
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nosocomial amphotericin B. Current status.
    Sarosi GA.
    Arch Intern Med; 1989 Nov 21; 149(11):2402-3. PubMed ID: 2818101
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.